Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,563 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Salvage-line Nivolumab Monotherapy for Advanced Esophageal Squamous Cell Carcinoma: Comparison of 240 mg Versus 480 mg Doses.
Murashima Y, Yamamoto S, Hirose T, Kadono T, Ikeda G, Ohara A, Itoyama M, Yokoyama K, Honma Y, Ishiyama K, Oguma J, Daiko H, Kato K. Murashima Y, et al. Among authors: yamamoto s. J Gastrointest Cancer. 2024 Sep;55(3):1345-1351. doi: 10.1007/s12029-024-01092-w. Epub 2024 Jul 15. J Gastrointest Cancer. 2024. PMID: 39007963 Free PMC article.
Pembrolizumab for the treatment of esophageal cancer.
Yamamoto S, Kato K. Yamamoto S, et al. Expert Opin Biol Ther. 2020 Oct;20(10):1143-1150. doi: 10.1080/14712598.2020.1792881. Epub 2020 Jul 14. Expert Opin Biol Ther. 2020. PMID: 32620063 Review.
Immuno-oncology for esophageal cancer.
Yamamoto S, Kato K. Yamamoto S, et al. Future Oncol. 2020 Nov;16(32):2673-2681. doi: 10.2217/fon-2020-0545. Epub 2020 Aug 11. Future Oncol. 2020. PMID: 32777942
Short-term outcomes of induction chemotherapy with docetaxel, cisplatin, and fluorouracil (TPF) in locally advanced nasopharyngeal carcinoma.
Takamizawa S, Honma Y, Murakami N, Mori T, Oka H, Yamamoto S, Kashihara T, Ito K, Kubo Y, Ikeda A, Matsumoto F, Omura G, Kobayashi K, Itami J, Kato K, Yoshimoto S. Takamizawa S, et al. Among authors: yamamoto s. Invest New Drugs. 2021 Apr;39(2):564-570. doi: 10.1007/s10637-020-00999-y. Epub 2020 Sep 17. Invest New Drugs. 2021. PMID: 32940872
Nivolumab for the treatment of esophageal cancer.
Mikuni H, Yamamoto S, Kato K. Mikuni H, et al. Among authors: yamamoto s. Expert Opin Biol Ther. 2021 Jun;21(6):697-703. doi: 10.1080/14712598.2021.1904887. Epub 2021 Mar 29. Expert Opin Biol Ther. 2021. PMID: 33736560
Emerging data on nivolumab for esophageal squamous cell carcinoma.
Hirose T, Yamamoto S, Kato K. Hirose T, et al. Among authors: yamamoto s. Expert Rev Gastroenterol Hepatol. 2021 Aug;15(8):845-854. doi: 10.1080/17474124.2021.1948836. Epub 2021 Jul 12. Expert Rev Gastroenterol Hepatol. 2021. PMID: 34251958 Review.
10,563 results
You have reached the last available page of results. Please see the User Guide for more information.